Did you mean?
Search Results - Showing 0 - 12 Of 30
_utilizing-common-viruses-to-combat-dangerous-cancers-hear-from-the-leaders-at-theriva-therapeutics.webp "Theriva is developing highly differentiated oncolytic adenoviruses that are designed to overcome the challenges of accessibility, availability, and administration and can potentially enable multiple dosing to improve efficacy.<br/><br/>The unique therapeutic properties of Theriva’s oncolytic viruses represent a new class of cancer treatments that are designed to selectively destroy tumor cells and enhance the effects of current standard-of-care therapies. Engineered for systemic delivery, Theriva’s oncolytic viruses can be administered intravenously or as a direct injection into the tumor or tumor compartment (intratumoral, intravitreal).")
Utilizing Common Viruses To Combat Dangerous Cancers - Hear From The Leaders At Theriva Therapeutics
⏲ 14:46 👁 7.9M
_crispr-therapeutics-ceo-science-in-gene-editing-is-moving-at-break-neck-speed.webp "CNBC Television")
⏲ 3 minutes 39 seconds 👁 9.7K
_cell-therapies-amp-the-future-of-biotech-124.webp "SALT")
_the-ceo-of-this-innovative-biopharma-is-bringing-light-to-cancer-research.webp "Paul Peter Tak, MD, PhD, FMedSci, President & CEO of Candel Therapeutics, was recently a guest on Benzinga's All-Acess.<br/><br/>Candel is a clinical-stage biopharmaceutical company focused on developing immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The company has two main platforms that are currently undergoing clinical trials. <br/><br/>Candel also has its enLIGHTEN™ program, a systematic, iterative discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.")
_episode-3-how-to-start-your-own-biotech-company-part-1-therapeutics.webp "NCI Scientific Events and Resources")
_2024-ceo-chat-conley-chee-ceo-of-syros-pharmaceuticals.webp "Flagship Pioneering")
_cathie-wood-9234mark-my-words-everyone-who-own-these-3-stocks-will-become-millionaire-by-end-of-20249234.webp "Millionaires Investment Secrets")
⏲ 14 minutes 56 seconds 👁 250.1K
_reaction-cathie-wood-on-crispr-amp-genomic-stocks.webp "The Market Mindset")
_crispr39s-next-advance-is-bigger-than-you-think-124-jennifer-doudna-124-ted.webp "TED")
⏲ 7 minutes 37 seconds 👁 335.4K
_crsp-stock-on-wild-ride-after-fda39s-historic-approval-these-gene-editing-treatments-could-be-next.webp "Alexis Garcia")
⏲ 15 minutes 51 seconds 👁 55K
_the-age-of-crispr-engineering-the-future-of-genetic-medicine-124-benjamin-oakes-124-tedxberkeley.webp "TEDx Talks")
⏲ 15 minutes 25 seconds 👁 518
_intellia-stock-vs-crispr-stock-the-winner-is.webp "Nanalyze")
![[+]](/images/menu.gif){kind=small}